ACTRN12614001295639
Completed
未知
The Clinical Utility of Glycated Albumin as an Index of Glycaemic Control in Type 1 Diabetic Pregnancy and its ability to predict Neonatal Outcome
orthern Sydney Local Health District0 sites30 target enrollmentDecember 11, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 1 Diabetes
- Sponsor
- orthern Sydney Local Health District
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 1 diabetes mellitus
- •\- 11\-18 weeks of gestation
- •\- Aged \> 18 years
Exclusion Criteria
- •\- Severe renal impairment \- \> stage 3 chronic kidney disease
- •\- Severe hepatic derangement \- AST \> 3 times upper limit of normal and/or ALT \> 3 times upper limit of normal
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Serum albumin-adjusted glycated albumin is a useful indicator of glycemic control in diabetic patients with end-stage renal disease not on hemodialysisPatients with diabetic nephropathy CKD4-5JPRN-UMIN000015174Kurume University School of Medicine30
Completed
Not Applicable
Predictive value of glycated albumin (GA%) versus glycosylated hemoglobin (HbA1c%) in follow up of glucose homeostasis in hemodialysis-maintained type -2 diabetic patientsNutritional, Metabolic, EndocrinePACTR201910650895114Elham Ahmed60
Not yet recruiting
Not Applicable
Glycated Albumin in Type 2 Diabetes MellitusCTRI/2024/06/068572Dept Of General Medicine
Active, not recruiting
Not Applicable
Testing a new approach for modifying the characteristics of the gumsThin gingival phenotypeOral HealthISRCTN18042063Damascus University20
Recruiting
Phase 1
A study for the usefulness of blood glycated albumin measurement by deliverytype 2 diabetesJPRN-UMIN000046088Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo98